Assay validation for KIM-1: human urinary renal dysfunction biomarker.
about
Novel biomarkers of acute kidney injury: Evaluation and evidence in urologic surgeryUrinary kidney injury molecule 1 (KIM-1) and interleukin 18 (IL-18) as risk markers for heart failure in older adults: the Health, Aging, and Body Composition (Health ABC) StudyAssociation of urinary injury biomarkers with mortality and cardiovascular events.Analysis of a urinary biomarker panel for obstructive nephropathy and clinical outcomesKIM-1 and NGAL: new markers of obstructive nephropathyPeritoneal dialysis does not adversely affect kidney function recovery after congenital heart surgeryKidney injury molecule-1 as a predicting factor for inflamed kidney, diabetic and diabetic nephropathy Egyptian patientsGlomerular expression of kidney injury molecule-1 and podocytopenia in diabetic glomerulopathy.The association between urinary kidney injury molecule 1 and urinary cadmium in elderly during long-term, low-dose cadmium exposure: a pilot study.Temporal relationship and predictive value of urinary acute kidney injury biomarkers after pediatric cardiopulmonary bypassSubclinical kidney injury before and 1 year after bariatric surgery among adolescents with severe obesity.Pediatric reference ranges for acute kidney injury biomarkersFurosemide Stress Test and Biomarkers for the Prediction of AKI Severity.Towards a biomarker panel for the assessment of AKI in children receiving intensive careAPOL1 Genotype and Glomerular and Tubular Kidney Injury in Women With HIV.Long-term Stability of Urinary Biomarkers of Acute Kidney Injury in ChildrenUrinary markers of kidney injury and kidney function decline in HIV-infected womenFollow-Up Renal Assessment of Injury Long-Term After Acute Kidney Injury (FRAIL-AKI).Development of a Novel Renal Activity Index of Lupus Nephritis in Children and Young Adults.Urine Injury Biomarkers and Risk of Adverse Outcomes in Recipients of Prevalent Kidney Transplants: The Folic Acid for Vascular Outcome Reduction in Transplantation Trial.Does HIV infection promote early kidney injury in women?Urinary biomarkers of kidney injury are associated with all-cause mortality in the Women's Interagency HIV Study (WIHS).Metabolomics for early detection of drug-induced kidney injury: review of the current status.Cell- and biomarker-based assays for predicting nephrotoxicity.Association of HIV infection with biomarkers of kidney injury and fibrosis in the Multicenter AIDS Cohort Study.Do serum and urinary concentrations of kidney injury molecule-1 in healthy newborns depend on birth weight, gestational age or gender?Kidney Injury Molecule-1 Enhances Endocytosis of Albumin in Renal Proximal Tubular Cells.Urinary kidney injury biomarkers and tobramycin clearance among children and young adults with cystic fibrosis: a population pharmacokinetic analysis.Development of Biomarker Models to Predict Outcomes in Lupus Nephritis.Brief Report: Cumulative Tenofovir Disoproxil Fumarate Exposure is Associated With Biomarkers of Tubular Injury and Fibrosis in HIV-Infected Men.Use of urine biomarker-derived clusters to predict the risk of chronic kidney disease and all-cause mortality in HIV-infected womenBiologic monitoring and surveillance results for the department of veterans affairs' depleted uranium cohort: Lessons learned from sustained exposure over two decades.Development and validation of panoptic Meso scale discovery assay to quantify total systemic interleukin-6.Urinary netrin-1 and KIM-1 as early biomarkers for septic acute kidney injury.Albuminuria correlates with hemolysis and NAG and KIM-1 in patients with sickle cell anemia.Serum and urinary NGAL but not KIM-1 raises in human postrenal AKI.Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient.Effects of age and gender on reference levels of biomarkers comprising the pediatric Renal Activity Index for Lupus Nephritis (p-RAIL).Urinary L-FABP and anaemia: distinct roles of urinary markers in type 2 diabetes.Urinary kidney injury molecule 1 and incidence of heart failure in elderly men.
P2860
Q26862812-ECE5D341-2593-48D8-9C89-89DDB2421272Q33800995-2397BE9C-9C0F-415C-9B47-92A46BC69561Q33814882-E7295506-C9BC-4433-8F87-B2276D9452CAQ34525437-DBBFC6DF-606C-436D-B7F5-4271834B9417Q34594776-9D609287-76D8-4F68-A44A-776C2371D152Q35006633-F0202017-B07C-420D-8765-4CE3A90447B7Q35141979-481CE91F-84AC-4995-8B6A-2D825D860F13Q35203400-EBDA245A-8C8A-46A3-B2D1-3824D1B7E713Q35221627-A1AD358B-FDDA-4FCE-953C-F4FDE9826F8EQ35563765-1E781063-D4AD-4A8A-A025-9516F4EB3C39Q35655805-1297202F-6538-472C-A0D1-E51298E70864Q35857141-B23FC699-73B3-4CF3-A3B7-16DFE7AC862DQ35903114-8D9AA879-F3EE-47DB-A89D-377C69EF45B6Q35995907-529EBCE8-9CFE-4326-A171-F21035E13324Q36191484-08C7EA93-497E-4FF6-A79D-B8B5D8137A30Q36328500-0FB33800-3E70-486D-8E65-1206C6865D16Q36431302-0CC9A031-E371-4B97-A744-EF5F608F9BDFQ36432903-6974BC10-2CD6-43F5-BD7E-AB947B0D8689Q36805078-C24488B7-E636-486E-817A-0F74925B2484Q37051993-BA23AE5B-9483-4F80-9295-918C26AF5756Q37600838-C35B4102-A1CD-4A6F-B989-53E2CBCDB585Q37684606-F3DD7C55-222E-4B1A-9ECD-93A2D6EF39D3Q37810166-D5F1A747-7CBD-4878-B3E0-F762AF4A54B9Q38266417-32A9A7A2-3DA5-4966-A7E4-CD9DB92BD44AQ38774632-0191D9C1-9088-4C52-B9A9-1EE318252460Q38816521-2F3BA468-EA6C-42A1-966A-8F341A85581FQ38838553-32F49CB3-E950-4132-959A-40160EFCEB76Q39431158-4CF381E1-1CB3-4D7D-BE2C-BC307E6F2257Q40352736-D8222F4E-9523-4669-A171-4EE1F3193D39Q40710519-56ED28F7-C414-4BD5-BCF4-42FC1BD66154Q40837133-4514BB3D-2456-4E11-AFE2-FD9C2BADA447Q41020669-67EAC873-A4FF-4652-82D9-9D84F43BBBA5Q41266576-0470F26F-0B7B-4F97-A35D-59416E906032Q42198113-2D89DF0D-94BE-4939-9A68-F02BE8B74CC4Q42215011-A014ACDB-DEFB-4EDB-AB7E-88CDEA708508Q42218148-9632B9B3-F6E9-455A-94ED-52C168BB7BC2Q42259357-6ED25A07-3314-47A2-ACA6-EF6BD1AAD784Q42377378-1F9C8663-36A2-4ECF-A7E3-047F1AB1B5F8Q43242660-EE6064CF-705B-4ABC-BBF3-5EBD1DB9375CQ43984225-CF3E41A5-837C-4BEB-BABD-BFD0D855E663
P2860
Assay validation for KIM-1: human urinary renal dysfunction biomarker.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Assay validation for KIM-1: human urinary renal dysfunction biomarker.
@en
Assay validation for KIM-1: human urinary renal dysfunction biomarker.
@nl
type
label
Assay validation for KIM-1: human urinary renal dysfunction biomarker.
@en
Assay validation for KIM-1: human urinary renal dysfunction biomarker.
@nl
prefLabel
Assay validation for KIM-1: human urinary renal dysfunction biomarker.
@en
Assay validation for KIM-1: human urinary renal dysfunction biomarker.
@nl
P2093
P2860
P356
P1476
Assay validation for KIM-1: human urinary renal dysfunction biomarker.
@en
P2093
Gordon F Kapke
Shalini Chaturvedi
Takeisha Farmer
P2860
P304
P356
10.7150/IJBS.5.128
P407
P577
2009-01-19T00:00:00Z